The global anti-vascular endothelial growth factor therapeutics market size was valued at USD 14.54 billion in 2024 and is anticipated to decline at a CAGR of -2.35% from 2025 to 2030. The emergence of biosimilars in the market is contributing to a significant decline in revenue. As thes... Read More »
November 2024The global celiac disease treatment market size was valued at USD 582.5 million in 2023 and is projected to grow at a CAGR of 11.8% from 2024 to 2030. This growth is attributed to the increasing prevalence of diagnosed cases, which has heightened the demand for effective treatments and d... Read More »
November 2024The global food allergy treatment market size was estimated at USD 6.87 billion in 2024 and is projected to grow at a CAGR of 8.27% from 2025 to 2030. Key factors propelling the market include the rising prevalence of food allergies worldwide and increasing R&D activities for novel d... Read More »
November 2024The global phenylketonuria treatment market size was valued at USD 518.7 million in 2024 and is projected to grow at a CAGR of 9.4% from 2025 to 2030. The market is driven by the increasing prevalence of phenylketonuria and rising healthcare expenditures that boost treatment accessibilit... Read More »
November 2024The global scleroderma therapeutics market was valued at USD 2.53 billion in 2024 and is projected to grow at a CAGR of 5.0% from 2025 to 2030. The increasing prevalence of autoimmune disease globally, the rising need to develop effective and advanced treatment options, and the growing e... Read More »
November 2024The global organ transplant immunosuppressant drugs market size was valued at USD 5.51 billion in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030. The increasing prevalence of chronic diseases that drive the need for organ transplants, the rising proportion of the geria... Read More »
November 2024The global weight loss supplement market size was estimated at USD 33.14 billion in 2024 and is projected to grow at a CAGR of 14.17% from 2025 to 2030. The rising cases of obesity and related health ailments, such as cardiovascular diseases, diabetes, and hypertension, are expected to d... Read More »
November 2024The global cholera vaccine market size was valued at USD 93.9 million in 2024 and is anticipated to grow at a CAGR of 10.0% from 2025 to 2030. The market is expected to grow due to increased awareness of cholera outbreaks in endemic regions. Various vaccination options and oral and injec... Read More »
November 2024The Morocco medical cannabis market size was estimated at USD 110.3 million in 2024 and is expected to grow at a CAGR of 42.9% from 2025 to 2030. The growth of the industry in the country is driven by several factors, including the increasing legalization of medical marijuana in the coun... Read More »
November 2024The global pharmaceutical contract packaging market size was valued at USD 17.6 billion in 2024 and is anticipated to grow at a CAGR of 7.1% from 2025 to 2030. Driven by the increasing trend of outsourcing packaging operations to specialized contract packaging companies. Facing pre... Read More »
November 2024The global cold pain therapy market size was estimated at USD 2.44 billion in 2024 and is projected to grow at a CAGR of 4.0% from 2025 to 2030. According to the CDC, approximately 54 million adults in the U.S. are diagnosed with arthritis, a leading condition within this category. With ... Read More »
November 2024The global non-opioid pain patches market size was estimated at USD 991.6 million in 2024 and is projected to grow at a CAGR of 6.2% from 2025 to 2030. The alarming increase in opioid prescriptions and related overdose deaths has prompted healthcare providers and patients to seek effecti... Read More »
November 2024The global botanicals and acupuncture market size was valued at USD 65.1 billion in 2024 and is anticipated to grow at a CAGR of 21.2% from 2025 to 2030. Wide acceptance for the manufacturing of multicomponent drugs is expected to increase the penetration rate of botanicals in the medica... Read More »
November 2024The global enzyme replacement therapy market size was valued at USD 10.37 billion in 2024 and is expected to grow at a CAGR of 9.0% from 2025 to 2030. This growth is attributed to the increasing prevalence of genetic disorders, particularly lysosomal storage diseases. In addition, advanc... Read More »
November 2024The global castrate-resistant prostate cancer market size was valued at USD 12.95 billion in 2024 and is projected to grow at a CAGR of 8.7% from 2025 to 2030. This growth is driven by the rising prevalence of prostate cancer, particularly among aging populations, which is contributing t... Read More »
November 2024The global digestive & intestinal remedies market size was estimated at USD 21.50 billion in 2024 and is projected to grow at a CAGR of 4.25% from 2025 to 2030. The market for digestive medicine products, such as Perenterol, Iberogast, and Dulcolax, is experiencing significant growth... Read More »
November 2024The global non-alcoholic steatohepatitis treatment market size was estimated at USD 7.72 billion in 2024 and is projected to grow at a CAGR of 28.1% from 2025 to 2030. The incidence of non-alcoholic steatohepatitis is increasing globally, largely due to lifestyle factors such as poor die... Read More »
November 2024The global paracetamol IV market size was valued at USD 798.25 million in 2024 and is expected to grow at a CAGR of 3.43% from 2025 to 2030. The growth is primarily driven by its application in pain management and fever reduction in post-surgical procedures. Intravenous administration of... Read More »
November 2024The global anticoagulant reversal drugs market size was estimated at USD 1.38 billion in 2024 and is projected to grow at a CAGR of 12.3% from 2025 to 2030, driven by the rising incidence of thromboembolic disorders. In addition, an aging population increases the prevalence of conditions... Read More »
November 2024The global GLP-1 receptor agonist market size was estimated at USD 53.46 billion in 2024 and is projected to grow at a CAGR of 17.46% from 2025 to 2030. The launch of new glucagon-like peptide 1 (GLP-1) receptor agonist products, a strong product pipeline for both diabetes & obesity ... Read More »
November 2024